Although the administration method seems ideal for prehospital use, the complexities of stroke assessment — including CT ...

Before TNKase, Activase was the only pharmacological treatment ... Genentech said it will also introduce a new 25mg vial ...

The manufacturer of TNKase, Genetech said a new 25-mg vial configuration will also be available in the coming months. The approval came at the backdrop of a study that compared TNKase to Activase ...